Phytochemical based Therapy for Covid taste loss disorder and inflammation

  • Subramani from QuickGun LifeScience
  • From India
  • Responsive
  • Innovative Products and Technologies

Summary of the technology

Our team of scientists have developed a pytochemical formulation for Covid which reduces viral load and inflammation. Its is useful in taste loss disorder. Its a combination of CBD-THC and a plant based alkaloid. They have safety profile of over 40 years. We have successfully formulated a rotocap based delivery system. We need strategic partners.

Details of the Technology Offer

Please connect with us for more details

Intellectual property status

Patent already applied for

Patent application number : 202021029007

Where : India

Related Keywords

  • Biological Sciences
  • Protecting Man and Environment
  • Genetic Engineering / Molecular Biology
  • Covid-19
  • covid

About QuickGun LifeScience

R&D company focused on holding intellectual proprties and brands.

Subramani Naidu

Never miss an update from Subramani Naidu

Create your free account to connect with Subramani Naidu and thousands of other innovative organizations and professionals worldwide


Send a request for information
to Subramani

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.


Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support